PRAX
Praxis Precision Medicines, Inc.
Praxis Precision Medicines, Inc. (PRAX) has 7 SEC Form 4 filings (21 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Jul 8, 2026.
Insiders have net sold $3.6M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Marcio Silva De'Souza
- Employees:168
- HQ:Boston, MA, US
- IPO:2020-10-16
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$3.6M
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Market Cap
$9.1B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
DeSimone JillFirst filing | Director | Sale | 11,600 | $3.6M | Jun 26 | SEC ↗ |
Related companies
Praxis Precision Medicines, Inc. is in the Healthcare sector.